Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndromes

Eur J Haematol. 2015 Jun;94(6):463. doi: 10.1111/ejh.12521. Epub 2015 Mar 16.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / analogs & derivatives*
  • Azacitidine / therapeutic use*
  • DNA Modification Methylases / antagonists & inhibitors*
  • Female
  • Humans
  • Male
  • Myelodysplastic Syndromes / mortality*
  • Myelodysplastic Syndromes / therapy*

Substances

  • Antimetabolites, Antineoplastic
  • DNA Modification Methylases
  • Azacitidine